期刊
PHARMACEUTICS
卷 14, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics14091861
关键词
cancer; DNA vaccination; gene therapy; tumor-specific antigens; apoptosis; plasmids; non-viral gene therapy; tumor-specific promoters; plasmid optimization
资金
- National Council for Science and Technology (CONACYT) [255725]
- Programa de Apoyo a la Investigacion Cientifica y Tecnologica [199-CS-2022]
- Universidad Autonoma de Nuevo Leon - Universidad Autonoma de Nuevo Leon
The interest in using nucleic acids for therapeutic applications is increasing. DNA molecules can be manipulated to express genes for gene therapy or vaccine development. DNA vaccination has shown potential for stimulating the immune system against cancer cells, while plasmid DNA can directly kill cancer cells. Promising results in animal models suggest that these DNA strategies may soon be approved for cancer treatment.
Recently, the interest in using nucleic acids for therapeutic applications has been increasing. DNA molecules can be manipulated to express a gene of interest for gene therapy applications or vaccine development. Plasmid DNA can be developed to treat different diseases, such as infections and cancer. In most cancers, the immune system is limited or suppressed, allowing cancer cells to grow. DNA vaccination has demonstrated its capacity to stimulate the immune system to fight against cancer cells. Furthermore, plasmids for cancer gene therapy can direct the expression of proteins with different functions, such as enzymes, toxins, and cytotoxic or proapoptotic proteins, to directly kill cancer cells. The progress and promising results reported in animal models in recent years have led to interesting clinical results. These DNA strategies are expected to be approved for cancer treatment in the near future. This review discusses the main strategies, challenges, and future perspectives of using plasmid DNA for cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据